Filing Flows › LifeMD (LFMD) › Q2 2026
LifeMD (LFMD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
LifeMD (LFMD) reported revenue of $47.3M for the second quarter 2026 (Q2 2026), -4% from a year earlier and -6% from the quarter before. Operating margin was -15.1%, net loss $7.1M (15.0% of revenue).
LifeMD, Q2 2026: revenue $47.3M (-4% year over year), operating margin -15.1%, net loss $7.1M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $47.3M | -6% | -4% |
| Operating profit | −$7.1M | — | — |
| Net earnings | −$7.1M | — | — |
| Operating cash flow | −$6.9M | -1658% | -180% |
What changed
Revenue was $47.3M in Q2 2026, down 4% year over year and down 6% from the previous quarter. Telehealth Subscription Revenue was the largest line at 62% of revenue. Telehealth lost $2.0M year over year (down 10%), 115% of the total change.
Gross margin was 88.8%, up 2.8 points from Q2 2025. Operating costs exceeded revenue by $7.1M, an operating margin of -15.1%. Operating expenses grew 10% against a revenue fall of 4%. The fastest-growing cost line was Sales & marketing (+27%). The quarter ended with a net loss of $7.1M, narrower than the previous quarter's $8.9M loss.
Operating cash flow was −$6.9M. Non-cash charges added back $325K of depreciation and amortization and $790K of share-based compensation. Working capital and other items used $1.0M. Capital expenditures of $1.7M exceeded it, leaving free cash flow of −$8.6M.
Questions
What was LifeMD's revenue in the second quarter 2026?
LifeMD (LFMD) reported revenue of $47.3M for the second quarter 2026 (Q2 2026), -4% from a year earlier and -6% from the quarter before.
Was LifeMD profitable in the second quarter 2026?
Operating loss was $7.1M (-15.1% of revenue) and net loss $7.1M.
Source: LifeMD 10-Q on SEC EDGAR.